Both in Pharmaceuticals
Verastem vs Geron
Over the past year VSTM returned −11.2% and GERN returned −3.9%; their daily moves had a correlation of 0.24.
VSTM −11.2% GERN −3.9%Growth of $1, one year, split-adjusted
| Metric | VSTM | GERN |
|---|---|---|
| Price | $8.25 | $1.22 |
| Market cap | $747.1M | $783.8M |
| Today | −1.55% | −0.41% |
| 1 month | +12.7% | −9.6% |
| 6 months | +45.8% | −29.5% |
| Year to date | +6.9% | −7.6% |
| 1 year | −10.7% | −12.2% |
| Revenue growth (YoY) | +1775.4% | +17.2% |
| Gross margin | 89.9% | 83.9% |
| Net margin | −86.5% | −29.0% |
| P/E (TTM) | — | — |
| Price / sales | 8.5× | 3.8× |
| Net cash | $54.6M | $51.1M |
| Dividend yield | — | — |
| Volatility (60d) | 58.5% | 63.6% |
| Short % of float | 17.7% | 11.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).